Hasil Pencarian - Sichu Liu

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    A Multi-Criteria Assessment Model for Cooperative Technology Transfer Projects from Universities to Industries

    A Multi-Criteria Assessment Model for Cooperative Technology Transfer Projects from Universities to Industries oleh Rui Xiong, Hongyi Sun, Shufen Zheng, Sichu Liu

    Diterbitkan 2024-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma

    Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma oleh Cunte Chen, Sichu Liu, Xinmiao Jiang, Ling Huang, Feili Chen, Xiaojun Wei, Hanguo Guo, Yang Shao, Yangqiu Li, Wenyu Li

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma

    TNFAIP3 mutation may be associated with favorable overall survival for patients with T-cell lymphoma oleh Cunte Chen, Zheng Chen, Ling Huang, Lingling Zhou, Lihua Zhu, Sichu Liu, Gengxin Luo, Wenyu Li, Chengwu Zeng, Yangqiu Li

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells

    The c-Myc-regulated lncRNA NEAT1 and paraspeckles modulate imatinib-induced apoptosis in CML cells oleh Chengwu Zeng, Sichu Liu, Shuai Lu, Xibao Yu, Jing Lai, Yifan Wu, Shaohua Chen, Liang Wang, Zhi Yu, Gengxin Luo, Yangqiu Li

    Diterbitkan 2018-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib‐based combination therapy: A real‐world experience of off‐label ibrutinib use

    Clinical outcomes of newly diagnosed primary CNS lymphoma treated with ibrutinib‐based combination therapy: A real‐world experience of off‐label ibrutinib use oleh Feili Chen, Diwen Pang, Hanguo Guo, Qiuxiang Ou, Xue Wu, Xinmiao Jiang, Xiaojuan Wei, Sichu Liu, Ling Huang, Zhanli Liang, Dong Zhou, Wenyu Li

    Diterbitkan 2020-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: